MYC expression cooperates with RB1 and TRP53 loss in the mouse lung to promote aggressive, highly metastatic tumors, initially sensitive to chemotherapy and then relapsing, similar to human SCLC. The gene discussed is TP53; the disease is small cell lung carcinoma.